Healio2d
VIDEO: Triplet therapy improved PFS in relapsed, refractory follicular lymphoma
Healio spoke with Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, about results from the inMind ...
Targeted Oncology1d
What Is Dark Zone Lymphoma, and Is It Clinically Relevant?
Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...
Targeted Oncology4d
Key Considerations for the Evolving Treatment Landscape for Relapsed/Refractory Follicular Lymphoma
A panelist discusses how various antibody-drug conjugates, including polatuzumab vedotin, pinatuzumab vedotin, and ...
2minutemedicine.com7d
Incyte: Monjuvi improves survival in patients with relapsed or refractory follicular lymphoma
The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients ...
Cure Today11d
Understanding the Intricacies of CAR-T Cell Therapy and Care in Hematologic Malignancies
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
Managed Healthcare Executive4d
ADC Loncastuximab Tesirine Induces High Response Rates in Patients with High-Risk Follicular Lymphoma and Marginal Zone Lymphoma
At the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition last month, the company announced positive ...